Viewing Study NCT07226856


Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2026-02-20 @ 10:42 PM
Study NCT ID: NCT07226856
Status: RECRUITING
Last Update Posted: 2025-12-22
First Post: 2025-11-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
Sponsor: Mayo Clinic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Pancreatic Adenocarcinoma View
None Recurrent Pancreatic Adenocarcinoma View
None Stage IV Pancreatic Cancer AJCC v8 View
Keywords: